239 related articles for article (PubMed ID: 31722348)
1. Survey of Mast Cell Mediator Levels from Patients Presenting with Symptoms of Mast Cell Activation.
Butterfield JH
Int Arch Allergy Immunol; 2020; 181(1):43-50. PubMed ID: 31722348
[TBL] [Abstract][Full Text] [Related]
2. Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.
Ravi A; Butterfield J; Weiler CR
J Allergy Clin Immunol Pract; 2014; 2(6):775-8. PubMed ID: 25439370
[TBL] [Abstract][Full Text] [Related]
3. Mast Cell Mediators of Significance in Clinical Practice in Mastocytosis.
Butterfield JH; Ravi A; Pongdee T
Immunol Allergy Clin North Am; 2018 Aug; 38(3):397-410. PubMed ID: 30007459
[TBL] [Abstract][Full Text] [Related]
4. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.
Divekar R; Butterfield J
Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439
[TBL] [Abstract][Full Text] [Related]
5. Increased Excretion of Mast Cell Mediator Metabolites During Mast Cell Activation Syndrome.
Butterfield JH
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2542-2546. PubMed ID: 36863614
[TBL] [Abstract][Full Text] [Related]
6. Increased leukotriene E4 excretion in systemic mastocytosis.
Butterfield JH
Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):73-6. PubMed ID: 20380889
[TBL] [Abstract][Full Text] [Related]
7. The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome.
Butterfield J; Weiler CR
J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2533-2541. PubMed ID: 32142966
[TBL] [Abstract][Full Text] [Related]
8. Urine Mast Cell Mediators in the Evaluation and Diagnosis of Mast Cell Activation Syndrome.
Voelker D; Pongdee T
Curr Allergy Asthma Rep; 2024 Feb; 24(2):33-38. PubMed ID: 38236528
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma.
Mita H; Endoh S; Kudoh M; Kawagishi Y; Kobayashi M; Taniguchi M; Akiyama K
Allergy; 2001 Nov; 56(11):1061-7. PubMed ID: 11703219
[TBL] [Abstract][Full Text] [Related]
10. Analytical and clinical validation of an LC-MS/MS method for urine leukotriene E4: A marker of systemic mastocytosis.
Lueke AJ; Meeusen JW; Donato LJ; Gray AV; Butterfield JH; Saenger AK
Clin Biochem; 2016 Sep; 49(13-14):979-82. PubMed ID: 26908217
[TBL] [Abstract][Full Text] [Related]
11. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
Butterfield JH; Weiler CR
Int Arch Allergy Immunol; 2008; 147(4):338-43. PubMed ID: 18622141
[TBL] [Abstract][Full Text] [Related]
12. Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis.
Ono E; Taniguchi M; Mita H; Fukutomi Y; Higashi N; Miyazaki E; Kumamoto T; Akiyama K
Clin Exp Allergy; 2009 Jan; 39(1):72-80. PubMed ID: 19128354
[TBL] [Abstract][Full Text] [Related]
13. Nontryptase Urinary and Hematologic Biomarkers of Mast Cell Expansion and Mast Cell Activation: Status 2022.
Butterfield JH
J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1974-1984. PubMed ID: 35346887
[TBL] [Abstract][Full Text] [Related]
14. Differential mast cell mediators in systemic mastocytosis and hereditary α-tryptasemia.
Giannetti MP; Godwin G; Weller E; Butterfield JH; Castells M
J Allergy Clin Immunol; 2022 Nov; 150(5):1225-1227. PubMed ID: 35550148
[TBL] [Abstract][Full Text] [Related]
15. Evidence for mast cell activation during exercise-induced bronchoconstriction.
O'Sullivan S; Roquet A; Dahlén B; Larsen F; Eklund A; Kumlin M; O'Byrne PM; Dahlén SE
Eur Respir J; 1998 Aug; 12(2):345-50. PubMed ID: 9727783
[TBL] [Abstract][Full Text] [Related]
16. Mast Cell Activation Syndrome.
Frieri M
Clin Rev Allergy Immunol; 2018 Jun; 54(3):353-365. PubMed ID: 25944644
[TBL] [Abstract][Full Text] [Related]
17. A US-Based Multicenter Retrospective Report of Perioperative Anaphylaxis, 2010-2021.
Gonzalez-Estrada A; Carrillo-Martin I; Morgenstern-Kaplan D; Rukasin CRF; Rank MA; Park MA; Yee CI; Volcheck GW
J Allergy Clin Immunol Pract; 2024 Jun; 12(6):1594-1602.e9. PubMed ID: 38580206
[TBL] [Abstract][Full Text] [Related]
18. Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management.
Castells M; Butterfield J
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1097-1106. PubMed ID: 30961835
[TBL] [Abstract][Full Text] [Related]
19. Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions.
O'Sullivan S; Roquet A; Dahlén B; Dahlén S; Kumlin M
Clin Exp Allergy; 1998 Nov; 28(11):1332-9. PubMed ID: 9824404
[TBL] [Abstract][Full Text] [Related]
20. Comparison of serum tryptase and urine N-methylhistamine in patients with suspected mastocytosis.
van Toorenenbergen AW; Oranje AP
Clin Chim Acta; 2005 Sep; 359(1-2):72-7. PubMed ID: 15913591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
